Search results
Results From The WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
Educational campaigns are thus essential in tackling prescription drug overuse, as it strengthens the public's understanding of prescription drug overuse. Promotion and training regarding proper prescription drug prescribing and dispensing, targeting healthcare professionals, can also enhance monitoring and prevention of overuse. [citation needed]
Founded in 1971 by Eric Schopler, TEACCH provides training and services geared to helping autistic children and their families cope with the condition. [2] [17] Gary B. Mesibov, a professor and researcher on UNC's TEACCH program since about 1979, was director of the program from 1992 to 2010. [18] [19]
The overuse of fluoroquinolone and other antibiotics fuels antibiotic resistance in bacteria, which can inhibit the treatment of antibiotic-resistant infections. [27] [28] [29] Their excessive use in children with otitis media has given rise to a breed of bacteria resistant to antibiotics entirely. [30]
Autism spectrum disorder [a] (ASD), or simply autism, is a neurodevelopmental disorder "characterized by persistent deficits in social communication and social interaction across multiple contexts" and "restricted, repetitive patterns of behavior, interests, or activities". [11] Sensory abnormalities are also included in the diagnostic manuals ...
The Journal of Autism and Developmental Disorders is a monthly peer-reviewed medical journal covering research on all aspects of autism spectrum disorders and related developmental disabilities. The journal was established in 1971 as the Journal of Autism and Childhood Schizophrenia , obtaining its current title in 1979. [ 1 ]
Molecular Autism is a peer-reviewed open-access medical journal covering research on the cause, biology, and treatment of autism and related neurodevelopmental disorders. The journal was established in 2010 and is published by BioMed Central .
It authorized nearly one billion dollars in expenditures over five years, starting in 2007, for screening, education, early intervention, prompt referrals for treatment and services, and research of the autism spectrum disorders of autism, Asperger syndrome, Rett syndrome, childhood disintegrative disorder, and pervasive developmental disorder ...